Antidiabetic and Antihyperlipidemic Properties of a Triterpenoid Compound, Dehydroeburicoic Acid, from Antrodia camphorata in Vitro and in Streptozotocin-Induced Mice

Journal of Agricultural and Food Chemistry

Volumn 63, Issue 46, 2015, Pages 10140-10151

  Kuo, Yueh Hsiung ^a,b   Lin, Cheng Hsiu ^c   Shih, Chun Ching ^d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

^c Ministry of Health and Welfare   (Taiwan)

^d CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

AMP activated protein kinase phosphorylation; Antrodia camphorata; dehydroeburicoic acid; diabetes; fatty acid synthase; glucose transporter 4; peroxisome proliferator activated receptor ; streptozotocin

Indexed keywords

BLOOD; CYTOLOGY; ENZYME ACTIVITY; ENZYME INHIBITION; GLUCOSE; MAMMALS; MEDICAL PROBLEMS; PHOSPHORYLATION;

AMP-ACTIVATED PROTEIN KINASE; ANTRODIA CAMPHORATA; FATTY ACID SYNTHASE; GLUCOSE TRANSPORTER 4; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; STREPTOZOTOCIN;

FATTY ACIDS;

ADIPONECTIN; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; DEHYDROEBURICOIC ACID; FATTY ACID SYNTHASE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; LANOSTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANALOGS AND DERIVATIVES; ANALYSIS; ANIMAL; ANTRODIA; BLOOD; C57BL MOUSE; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; GENE EXPRESSION; GENETICS; GLUCOSE BLOOD LEVEL; LIVER; MALE; METABOLISM; MOUSE; PATHOLOGY; PHOSPHORYLATION; PHYTOTHERAPY;

ADIPONECTIN; ADIPOSE TISSUE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTRODIA; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FATTY ACID SYNTHASES; GENE EXPRESSION; GLUCOSE TRANSPORTER TYPE 4; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INSULIN; LANOSTEROL; LIVER; MALE; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PHYTOTHERAPY; PPAR GAMMA; TRIGLYCERIDES;

EID: 84948439218     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/acs.jafc.5b04400     Document Type: Article

References (58)

1. Daneman, D. Type 1 diabetes Lancet 2006, 367 (9513) 847-858 10.1016/S0140-6736(06)68341-4
2. American Diabetes Association Clinical Guidelines, (2010.
3. Tian, H. L.; Wei, L. S.; Xu, Z. X. Correlations between blood glucose level and diabetes signs in streptozotocin-induced diabetic mice Global J. Pharmacol. 2010) 4 (3) 111-116
4. Hayashi, K.; Kojima, R.; Ito, M. Strain differences in the diabetogenic activity of streptozotocin in mice Biol. Pharm. Bull. 2006, 29 (6) 1110-1119 10.1248/bpb.29.1110
5. Islam, M. S.; Loots, D. T. Experimental rodent models of type 2 diabetes: a review Methods Find. Exp. Clin. Pharmacol. 2009, 31 (4) 249 10.1358/mf.2009.31.4.1362513
6. Islam, M. S.; Wilson, R. D. Experimentally induced rodent models of type 2 diabetes Methods Mol. Biol. 2012, 33, 161-174 10.1007/978-1-62703-068-7-10
7. Rossini, A. A.; Williams, R. M.; Appel, M. C.; Like, A. A. Sex differences in the multiple-dose streptozotocin model of diabetes Endocrinology 1978, 103 (4) 1518-1520 10.1210/endo-103-4-1518
8. Geethangili, M.; Tzeng, Y. M. Review of pharmacological effects of Antrodia camphorata and its bioactive compounds. Evidence-Based Complement. Altern. Med. 2011, 2011, No. 212641, 1 10.1093/ecam/nep108
9. Yeh, C. T.; Rao, Y. K.; Yao, C. J.; Yeh, C. F.; Li, C. H.; Chuang, S. E.; Luong, J. H.; Lai, G. M.; Tzeng, Y. M. Cytotoxic triterpenes from Antrodia camphorata and their mode of action in HT-29 human colon cancer cells Cancer Lett. 2009, 285, 73-79 10.1016/j.canlet.2009.05.002
10. Huang, G. J.; Huang, S. S.; Lin, S. S.; Shao, Y. Y.; Chen, C. C.; Hou, W. C. et al. Analgesic effects and the mechanisms of anti-inflammation of ergostatrien-3β-ol from Antrodia camphorata submerged whole broth in mice J. Agric. Food Chem. 2010, 58, 7445-7452 10.1021/jf1013764
11. 2+-NO-cAMP pathway Life Sci. 2003, 73, 2769-2783 10.1016/S0024-3205(03)00669-6
12. Huang, G. J.; Deng, J. S.; Huang, S. S.; Lee, C. Y.; Hou, W. C.; Hou, W. C.; Wang, S. Y.; Sung, P. J.; Kuo, Y. H. Hepatoprotective effects of eburicoic acid and dehydroeburicoic acid from Antrodia camphorata in a mouse model of acute hepatic injury Food Chem. 2013, 141, 3020-3027 10.1016/j.foodchem.2013.03.061
13. 4-induced hepatic toxicity in rats J. Agric. Food Chem. 2003, 51, 1571-1577 10.1021/jf0209701
14. Lee, J. H.; Lee, Y. J.; Shin, J. K.; Nam, J. W.; Nah, S. Y.; Kim, S. H. et al. Effects of triterpenoids from Poria cocos Wolf on the serotonin type 3A receptor-mediated ion current in Xenopus oocytes Eur. J. Pharmacol. 2009, 615 (1-3) 27-32 10.1016/j.ejphar.2009.04.063
15. Majid, E.; Male, K. B.; Tzeng, Y. M.; Omamogho, J. O.; Glennon, J. D.; Luong, J. H. Cyclodextrin-modified capillary electrophoresis for achiral and chiral separation of ergostane and lanostane compounds extracted from the fruiting body of Antrodia camphorata Electrophoresis 2009, 30 (11) 1967-1975 10.1002/elps.200800758
16. Huang, S.; Czech, M. P. The GLUT4 glucose transporter Cell Metab. 2007, 5 (4) 237-252 10.1016/j.cmet.2007.03.006
17. Lee, W.; Ryu, J.; Souto, R. P.; Pilch, P. E.; Jung, C. Y. Separation and partial characterization of three distinct intracellular GLUT4 compartments in rat adipocytes. Subcellular fractionation without homogenization J. Biol. Chem. 1999, 274 (53) 37755-37762 10.1074/jbc.274.53.37755
18. Watson, R. T.; Pessin, J. E. Intracellular organization of insulin signaling and GLUT4 translocation Recent Prog. Horm. Res. 2001, 56, 175-193 10.1210/rp.56.1.175
19. Sujatha, S.; Anand, S.; Sangeetha, K. N.; Shilpa, K.; Lakshmi, J.; Balakrishnan, A.; Lakshmi, B. S. Biological evaluation of (3b)-stigmast-5-en-3-ol as potent anti-diabetic agent in regulating glucose transport using in vitro model Int. J. Diabetes Mellitus 2010, 2, 101-109 10.1016/j.ijdm.2009.12.013
20. Foretz, M.; Taleux, N.; Guigas, B.; Horman, S.; Beauloye, C.; Andreelli, F. et al. Regulation of energy metabolism by AMPK: a novel therapeutic approach for the treatment of metabolic and cardiovascular diseases Med. Sci. (Paris) 2006, 22 (4) 381-383 10.1051/medsci/2006224381
21. Viollet, B.; Lantier, L.; Devin-Leclerc, J.; Hébrard, S.; Amouyal, C.; Mounier, R.; Foretz, M.; Andreelli, F. Targeting the AMPK pathway for the treatment of type 2 diabetes Front. Biosci., Landmark Ed. 2009, 14, 3380-3400 10.2741/3460
22. Zhou, G.; Myers, R.; Li, Y.; Chen, Y.; Shen, X.; Fenyk-Melody, J.; Wu, M.; Ventre, J.; Doebber, T.; Fujii, N.; Musi, N.; Hirshman, M. F.; Goodyear, L. J.; Moller, D. E. Role of AMP-activated protein kinase in mechanism of metformin action J. Clin. Invest. 2001, 108 (8) 1167-1174 10.1172/JCI13505
23. Stein, S. C.; Woods, A.; Jones, N. A.; Davison, M. D.; Carling, D. The regulation of AMP-activated protein kinase by phosphorylation Biochem. J. 2000, 345 (3) 437-443 10.1042/bj3450437
24. Tai, T.; Akahori, A.; Shingu, T. Triterpenes of Poria cocos Phytochemistry 1993, 32, 1239-1244 10.1016/S0031-9422(00)95099-4
25. Klip, A.; Ramlal, T.; Young, D. A.; Holloszy, J. O. Insulin-induced translocation of glucose transporters in rat hindlimb muscles FEBS Letters 1987, 224, 224-230
26. Shih, C. C.; Lin, C. H.; Lin, W. L.; Wu, J. B. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats J. Ethnopharmacol. 2009, 123, 82-90 10.1016/j.jep.2009.02.039
27. Tan, M. J.; Ye, J. M.; Turner, N.; Hohnen-Berhrens, C.; Ke, C. Q.; Tang, C. P. et al. Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway Chem. Biol. 2008, 15, 263-273 10.1016/j.chembiol.2008.01.013
28. Shih, C. C.; Chen, M. H.; Lin, C. H. Validation of the antidiabetic and hypolipidemic effects of Clitocybe nuda by assessment of glucose transporter 4 and gluconeogenesis and AMPK phosphorylation in streptozotocin-induced mice. Evidence-Based Complement. Altern. Med. 2014, 2014, No. 705636, 1 10.1155/2014/705636
29. Shih, C. C.; Lin, C. H.; Lin, W. L. Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet Diabetes Res. Clin. Pract. 2008, 81, 134-143 10.1016/j.diabres.2008.04.023
30. Shih, C. C.; Ciou, J. L.; Lin, C. H.; Wu, J. B.; Ho, H. Y. Cell suspension culture of Eriobotrya japonica regulates the diabetic and hyperlipidemic signs of high-fat-fed mice Molecules 2013, 18, 2726-2753 10.3390/molecules18032726
31. Wu, J. B.; Kuo, Y. H.; Lin, C. H.; Ho, Y. H.; Shih, C. C. Tormentic acid, a major component of suspension cells of Eriobotrya japonica, suppresses high-fat diet-induced diabetes and hyperlipidemia by glucose transporter 4 and AMP-activated protein kinase phosphorylation J. Agric. Food Chem. 2014, 62, 10717-10726 10.1021/jf503334d
32. Kuo, Y. H.; Lin, C. H.; Shih, C. C. Ergostatrien-3β-ol from Antrodia camphorata inhibits diabetes and hyperlipidemia in high-fat-diet treated mice via regulation of hepatic related genes, glucose transporter 4, and AMP-Activated protein kinase phosphorylation J. Agric. Food Chem. 2015, 63 (9) 2479-2489 10.1021/acs.jafc.5b00073
33. Changrani, N. R.; Chonkar, A.; Adeghate, E.; Singh, J. Effects of streptozotocin-induced type 1 diabetes mellitus on total protein concentrations and cation contents in the isolated pancreas, parotid, submandibular, and lacrimal glands of rats Ann. N. Y. Acad. Sci. 2006, 1084, 503-519 10.1196/annals.1372.019
34. Wiernsperger, N. F. Chapter 12. Preclinical pharmacology of biguanides. In Oral Antidiabetics; Kuhlmann, J.; Pulus, W., Eds.; Springer: Berlin, Germany, 1996.
35. Damci, T.; Tatliagac, S.; Osar, Z.; Ilkova, H. Fenofibrate treatment is associated with better glycemic control and lower serum leptin and insulin levels in type 2 diabetic patients with hypertriglyceridemia Eur. J. Intern. Med. 2003, 14, 357-360 10.1016/S0953-6205(03)90001-X
36. Choi, J. S.; Yokozawa, T.; Oura, H. Improvement of hyperglycemia and hyperlipidemia in streptozotocin-diabetic rats by a methanolic extract of Prunus davidiana stems and its main component, pruning Planta Med. 1991, 57 (3) 208-211 10.1055/s-2006-960075
37. Nabi, A. N.; Rahman, M.; Nislam, L. Plasma cholesterol modulate functions of neutrophils in streptozotocin-induced type 1 diabetic rats Bioj. Sci. Technol. 2014, 1, Article ID: m140000
38. Staels, B.; Fruchart, J. C. Therapeutic roles of peroxisome proliferator-activated receptor agonists Diabetes 2005, 54 (80) 2460-2470 10.2337/diabetes.54.8.2460
39. Szkudelski, T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas Physiol. Res. 2001, 50 (6) 537-546
40. Liu, S. H.; Chang, Y. H.; Chiang, M. T. Chitosan reduces gluconeogenesis and increases glucose uptake in skeletal muscle in streptozotocin-induced diabetic rats J. Agric. Food Chem. 2010, 58 (9) 5795-5800 10.1021/jf100662r
41. Welsh, G. I.; Hers, I.; Berwick, D. C.; Dell, G.; Wherlock, M.; Birkin, R.; Leney, S.; Tavaré, J. M. Role of protein kinase B in insulin-regulated glucose uptake Biochem. Soc. Trans. 2005, 33 (2) 346-349 10.1042/BST0330346
42. Nedachi, T.; Kanzaki, M. Regulation of glucose transporters by insulin transporter by insulin and extracellular glucose in C2C12 myotubes Am. J. Physiol. Endocrinol. Metab. 2006, 291 (4) E817-E828 10.1152/ajpendo.00194.2006
43. Guo, S. Insulin signaling, resistance, and metabolic syndrome: insights from mouse models into disease mechanisms J. Endocrinol. 2014, 220 (2) T1-T23 10.1530/JOE-13-0327
44. Barthel, A.; Schmoll, D. Novel concepts in insulin regulation of hepatic gluconeogenesis Am. J. Physiol. Endocrinol. Metab. 2003, 285 (4) E685-E692 10.1152/ajpendo.00253.2003
45. Berg, J. M.; Tymoczko, J. L.; Stryer, L. Glycolysis and glyconeogenesis. In Stryer Biochemistry; Berg, J. M.; Tymoczko, J. L., Eds.; Freeman: New York, 2001; pp 425-464.
46. O'Brien, R. M.; Printz, R. L.; Halmi, N.; Tiesinga, J. J.; Granner, D. K. Structural and functional analysis of the human phosphoenolpyruvate carboxykinase gene promoter Biochim. Biophys. Acta, Gene Struct. Expression 1995, 1264 (3) 284-288 10.1016/0167-4781(95)00194-8
47. Sutherland, C.; O'Brien, R. M.; Granner, D. K. New connections in the regulation of PEPCK gene expression by insulin Philos. Trans. R. Soc., B 1996, 351 (1336) 191-199 10.1098/rstb.1996.0016
48. Kim, Y. D.; Park, K. G.; Lee, Y. S.; Park, Y. Y.; Kim, D. K.; Nedumaran, B.; Jang, W. G.; Cho, W. J.; Ha, J.; Lee, I. K.; Lee, C. H.; Choi, H. S. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP Diabetes 2008, 57 (2) 306-314 10.2337/db07-0381
49. Wakil, S. Fatty acid synthase, a proficient multifunctional enzyme Biochemistry 1989, 28, 4523-4530 10.1021/bi00437a001
50. Patel, D. D.; Knight, B. L.; Wiggins, D.; Humphreys, S. M.; Gibbons, G. F. Disturbances in the normal regulation of SREBP-sensitive genes in PPAR α-deficient mice J. Lipid Res. 2001, 42 (3) 328-337
51. Zhou, G.; Myers, R.; Li, Y.; Chen, T.; Shen, X.; Fenyk-Melody, J. et al. Role of AMP-activated protein kinase in mechanism of metformin action J. Clin. Invest. 2001, 108, 1167-1174 10.1172/JCI13505
52. McGarry, J. D.; Brown, N. F. The mitochondrial carnitine palmitoyl-transferase system from concept to molecular analysis Eur. J. Biochem. 1997, 244, 1-14 10.1111/j.1432-1033.1997.00001.x
53. Cases, S.; Stone, S. J.; Zhou, P.; Yen, E.; Tow, B.; Lardizabal, K. D.; Voelker, T.; Farese, R. V., Jr. Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members J. Biol. Chem. 2001, 276 (42) 38870-38876 10.1074/jbc.M106219200
54. Shimano, H.; Shimomura, I.; Hammer, R. E.; Herz, J.; Goldstein, J. L.; Brown, M. S.; Horton, J. D. Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene J. Clin. Invest. 1997, 100 (8) 2115-2124 10.1172/JCI119746
55. Kersten, S. Peroxisome proliferator activated receptors and obesity Eur. J. Pharmacol. 2002, 440, 223-234 10.1016/S0014-2999(02)01431-0
56. Saladin, R. et al. Differential regulation of peroxisome proliferator activated receptor gamma1 (PPARgamma1) and PPARgamma2 messenger RNA expression in the early stages of adipogenesis Cell Growth Differ. 1999, 10, 43-48
57. Gil-Campos, M.; Canete, R.; Gil, A. Adiponectin, the missing link insulin resistance and obesity Clin. Nutr. 2004, 23, 963-974 10.1016/j.clnu.2004.04.010
58. Minokoshi, Y.; Kim, Y. B.; Kahn, B. B. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein Diabetes 2003, 51 (Suppl. 2) 1375